Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia. The gene discussed is XDH; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.